(Q77348606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Correlation between symptom fatigue and muscular fatigue in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

Iriarte J

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

de Castro P

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neurology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

579-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Neurobiology of muscle fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Neural mechanisms underlying the sensation of breathlessness: kinesthetic parallels between respiratory and limb muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Cardiovascular responses and the sense of effort during attempts to contract paralysed muscles: Role of the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Fatigue in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Experiencing symptoms in chronic illness: fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Reducing heterogeneity in chronic fatigue syndrome: a comparison with depression and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Low-threshold mechanoreceptive and nociceptive units with unmyelinated (C) fibres in the human supraorbital nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Serum interleukin 2 and soluble interleukin 2 receptor in patients with multiple sclerosis who are experiencing severe fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Excessive muscular fatigue in the postpoliomyelitis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Physiology of fatigue in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Illness behaviour in the chronic fatigue syndrome and multiple sclerosis. Disentangling common characteristics is not so easy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

An electrophysiological study of the mechanism of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

Reduction in excitability of the auditory nerve following electrical stimulation at high stimulus rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.1998.560579.X

10.1046/J.1468-1331.1998.560579.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10210893%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference